Cargando…
CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma
BACKGROUND: Osteosarcoma (OS) is a common malignant cancer in children and adolescents and has a cure rate that has not improved in the last two decades. CYT997 (lexibulin) is a novel potent microtubule-targeting agent with various anticancer activities, such as proliferation inhibition, vascular di...
Autores principales: | Wang, Zongyi, Yin, Fei, Xu, Jing, Zhang, Tao, Wang, Gangyang, Mao, Ming, Wang, Zhuoying, Sun, Wei, Han, Jing, Yang, Mengkai, Jiang, Yafei, Hua, Yingqi, Cai, Zhengdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357486/ https://www.ncbi.nlm.nih.gov/pubmed/30704503 http://dx.doi.org/10.1186/s13046-019-1047-9 |
Ejemplares similares
-
Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity
por: Teng, Yong, et al.
Publicado: (2017) -
MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma
por: Yang, Mengkai, et al.
Publicado: (2021) -
Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling
por: Jiang, Yafei, et al.
Publicado: (2021) -
Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent
por: Lickliter, J D, et al.
Publicado: (2010) -
Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients
por: Yang, Mengkai, et al.
Publicado: (2021)